Clinical Trials Browser

Interventional × Breast Cancer Metastatic × Irinotecan × Clear all

NCT03328884 2025-04-23

Phenomenal

Phase 2 Completed

Breast Cancer Metastatic

NCT00532714 2011-12-30

Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC

Phase 2 Completed

Breast Cancer Metastatic